Yellow Fever Vaccine Global Market Report 2026

Description

The yellow fever vaccine is a live, weakened viral vaccine designed to prevent yellow fever, a severe viral disease spread by mosquitoes. It is usually given as a single dose and offers long-term immunity, often for life. The vaccine is particularly crucial for individuals residing in or traveling to regions where the disease is common.

The primary forms of the yellow fever vaccine are powder and liquid. The yellow fever vaccine powder is a lyophilized (freeze-dried) version of the vaccine, which must be reconstituted with a specific diluent prior to administration to confer immunity against the yellow fever virus. This includes various treatment types, such as pain management medications and oral rehydration. The vaccine is utilized in routine immunization, for travelers, and other purposes, and is administered by several end users, mainly hospitals, diagnostic centers, point-of-care centers, and others.

Tariffs have affected the yellow fever vaccine market by increasing the cost of imported vaccine antigens, cold chain equipment, and sterile packaging materials. These impacts are most pronounced in both powder based and liquid vaccine formulations, particularly in developing regions that rely on external suppliers. Rising tariff related expenses have placed additional strain on public immunization budgets and government procurement programs. In some cases, this has contributed to delayed tenders and constrained vaccine availability. However, tariffs are encouraging regional vaccine manufacturing capabilities, technology transfer initiatives, and more resilient local supply chains over the long term.

The yellow fever vaccine market research report is one of a series of new reports from The Business Research Company that provides yellow fever vaccine market statistics, including yellow fever vaccine industry global market size, regional shares, competitors with a yellow fever vaccine market share, detailed yellow fever vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the yellow fever vaccine industry. This yellow fever vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The yellow fever vaccine market size has grown steadily in recent years. It will grow from $4.74 billion in 2025 to $4.97 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to recurring yellow fever outbreaks, government immunization mandates, established vaccine efficacy, international travel requirements, public health initiatives.

The yellow fever vaccine market size is expected to see steady growth in the next few years. It will grow to $5.88 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to climate-driven mosquito spread, increasing global travel, expansion of vaccination infrastructure, higher funding for disease prevention, stronger outbreak preparedness. Major trends in the forecast period include expansion of routine immunization programs, rising demand from international travelers, increased government-led vaccination campaigns, growing use of single-dose vaccines, focus on endemic disease prevention.

The growth of international travel is expected to drive the expansion of the yellow fever vaccine market in the coming years. International travel involves the movement of people across national borders for purposes such as tourism, business, or personal reasons. This trend is increasing due to rising global mobility, supported by economic recovery and the easing of post-pandemic travel restrictions. The yellow fever vaccine market caters to travelers by offering mandatory or recommended immunization for entry into areas where yellow fever is prevalent. For example, in January 2024, the World Tourism Organization (UNWTO) reported that a Spain-based international tourism agency recorded 1.286 billion global international tourist arrivals in 2023, up from 0.96 billion in 2022, marking a year-on-year increase of 0.326 billion international tourists. Consequently, the rise in international travel is contributing to the growth of the yellow fever vaccine market.

Major companies in the yellow fever vaccine market are increasingly emphasizing the development of innovative solutions, such as T-cell adaptive booster vaccines, to enhance long-term immunity, improve vaccine effectiveness, and overcome the limitations of conventional live-attenuated vaccines. T-cell adaptive booster vaccines are designed to bolster the immune system by specifically stimulating T-cell responses, enabling the body to recognize and combat infections more efficiently compared to traditional antibody-centered vaccines. For example, in April 2025, the All India Institute of Medical Sciences, a healthcare institute based in India, launched Yellow Fever Vaccination to provide travelers with protection against the mosquito-borne viral disease and to issue the internationally recognized vaccination certificate. This initiative aims to improve vaccine accessibility within Telangana, minimizing the need for long-distance travel to other authorized centers. Furthermore, the program ensures compliance with international health regulations by offering safe administration under medical supervision, particularly for individuals with contraindications.

In November 2025, Mabloc, LLC, a biotechnology company based in the US, collaborated with Instituto Butantan to advance a first-in-class monoclonal antibody therapy for the treatment and prevention of yellow fever. This collaboration aims to develop a safe and effective post-exposure and preventive therapy for yellow fever, addressing the unmet medical need for disease-specific treatment. Instituto Butantan is a public research center and vaccine manufacturer based in Brazil.

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the yellow fever vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The yellow fever vaccine market consists of sales of vaccine syringes, needles, and vaccine storage equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Yellow Fever Vaccine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses yellow fever vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for yellow fever vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The yellow fever vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product: Powder; Liquid
2) By Application: Routine Immunization; Travelers; Other Applications
3) By End-User: Hospitals; Diagnostic Centers; Point Of Care Centers; Other End Users
Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution; Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine; Liquid Vaccine In Pre-Filled Syringes
Companies Mentioned: Sanofi S.A.; Bio-Manguinhos; Institut Pasteur de Dakar; Instituto Butantan; Bio Farma; Biological E. Limited; Beijing Tiantan Biological Products Co. Ltd.; Wuhan Institute of Biological Products; Merck & Co. Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Lonza Group AG; WuXi Biologics; Ology Bioservices; Valneva SE; Bavarian Nordic A/S; Panacea Biotec Ltd.; Biovac; Novavax Inc.; PnuVax Incorporated
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH6MYFVE01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Yellow Fever Vaccine Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Yellow Fever Vaccine Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Yellow Fever Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Yellow Fever Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Sustainability, Climate Tech & Circular Economy
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.5 Artificial Intelligence & Autonomous Intelligence
4.2. Major Trends
- 4.2.1 Expansion Of Routine Immunization Programs
- 4.2.2 Rising Demand From International Travelers
- 4.2.3 Increased Government-Led Vaccination Campaigns
- 4.2.4 Growing Use Of Single-Dose Vaccines
- 4.2.5 Focus On Endemic Disease Prevention

5. Yellow Fever Vaccine Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Government Immunization Centers
5.3 Travel Clinics
5.4 Public Health Facilities
5.5 Point Of Care Centers

6. Yellow Fever Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Yellow Fever Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Yellow Fever Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Yellow Fever Vaccine Market Size, Comparisons And Growth Rate Analysis
7.3. Global Yellow Fever Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Yellow Fever Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Yellow Fever Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Yellow Fever Vaccine Market Segmentation

9.1. Global Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Powder, Liquid
9.2. Global Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Routine Immunization, Travelers, Other Applications
9.3. Global Yellow Fever Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users
9.4. Global Yellow Fever Vaccine Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
9.5. Global Yellow Fever Vaccine Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

10. Yellow Fever Vaccine Market Regional And Country Analysis

10.1. Global Yellow Fever Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Yellow Fever Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Yellow Fever Vaccine Market

11.1. Asia-Pacific Yellow Fever Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Yellow Fever Vaccine Market

12.1. China Yellow Fever Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Yellow Fever Vaccine Market

13.1. India Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Yellow Fever Vaccine Market

14.1. Japan Yellow Fever Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Yellow Fever Vaccine Market

15.1. Australia Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Yellow Fever Vaccine Market

16.1. Indonesia Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Yellow Fever Vaccine Market

17.1. South Korea Yellow Fever Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Yellow Fever Vaccine Market

18.1. Taiwan Yellow Fever Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Yellow Fever Vaccine Market

19.1. South East Asia Yellow Fever Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Yellow Fever Vaccine Market

20.1. Western Europe Yellow Fever Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Yellow Fever Vaccine Market

21.1. UK Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Yellow Fever Vaccine Market

22.1. Germany Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Yellow Fever Vaccine Market

23.1. France Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Yellow Fever Vaccine Market

24.1. Italy Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Yellow Fever Vaccine Market

25.1. Spain Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Yellow Fever Vaccine Market

26.1. Eastern Europe Yellow Fever Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Yellow Fever Vaccine Market

27.1. Russia Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Yellow Fever Vaccine Market

28.1. North America Yellow Fever Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Yellow Fever Vaccine Market

29.1. USA Yellow Fever Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Yellow Fever Vaccine Market

30.1. Canada Yellow Fever Vaccine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Yellow Fever Vaccine Market

31.1. South America Yellow Fever Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Yellow Fever Vaccine Market

32.1. Brazil Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Yellow Fever Vaccine Market

33.1. Middle East Yellow Fever Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Yellow Fever Vaccine Market

34.1. Africa Yellow Fever Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Yellow Fever Vaccine Market, Segmentation By Product, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Yellow Fever Vaccine Market Regulatory and Investment Landscape

36. Yellow Fever Vaccine Market Competitive Landscape And Company Profiles

36.1. Yellow Fever Vaccine Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Yellow Fever Vaccine Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Yellow Fever Vaccine Market Company Profiles
- 36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Bio-Manguinhos Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Institut Pasteur de Dakar Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Instituto Butantan Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Bio Farma Overview, Products and Services, Strategy and Financial Analysis

37. Yellow Fever Vaccine Market Other Major And Innovative Companies

Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

38. Global Yellow Fever Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Yellow Fever Vaccine Market

40. Yellow Fever Vaccine Market High Potential Countries, Segments and Strategies

40.1 Yellow Fever Vaccine Market In 2030 - Countries Offering Most New Opportunities
40.2 Yellow Fever Vaccine Market In 2030 - Segments Offering Most New Opportunities
40.3 Yellow Fever Vaccine Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer